Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
02/1993
02/24/1993EP0528495A1 Azacyclic compounds, processes for their preparation and pharmaceutical compositions containing them
02/24/1993EP0528164A2 Use of xanthine derivatives for the manufacture of a medicament for the treatment of secondary nerve cell damages and function disorders after head-brain-traumata
02/24/1993EP0528026A1 New meso-azacyclic aromatic acid amides and esters as novel serotonergic agents
02/24/1993EP0527964A1 Tetrahydrobenzothienopyridines, processes for their preparation and their use as pharmaceuticals
02/24/1993EP0527962A1 Method, compositions, and compounds for modulating brain excitability
02/24/1993EP0527917A1 Use of adenosine and adenosine derivatives for anesthesia
02/24/1993EP0527869A1 Benzylimidazole derivatives as anxiolytic and nootropic agents
02/24/1993EP0527764A1 Phosphonopeptides with collagenase inhibiting activity
02/24/1993CN1069270A Heteraryloxy-beta-carboline, processes for its production and use in pharmaceutical agents
02/23/1993US5189212 Used in estrogen replacement therapy like menopause, osteoporosis therapy, prevention of excessive hair growth of body and infertility
02/23/1993US5189179 Serotonin 5ht1a agonists
02/23/1993US5189050 Fermentation analogs of virginiamycin m1 to treat panic and anxiety disorder
02/23/1993US5189045 Antiserotonine agent
02/23/1993US5189041 Gastrointestinal and nervous system disorders, cardiovascular disorders, analgesics
02/23/1993US5189033 Analgesics, antiiflammatory agents
02/23/1993US5189022 Using polypeptide
02/23/1993US5189018 Method for reduction of central nervous system (cns) edema resulting from head and spinal cord trauma
02/23/1993CA2076573A1 Benzodioxane derivatives
02/23/1993CA2076558A1 Pharmaceutical compositions containing bradykinin antagonists for local use on the nose and eyes
02/23/1993CA1313872C Acetamide derivatives of dihydro-2,3-phenyl-3 -benzofuran-2-one, processes for their preparation and pharmaceutical compositions containing them
02/23/1993CA1313871C Derivatives of (dihydro-2,3-oxo-2-benzofuranyl-3)-2- acetic acid, processes for their preparation and pharmaceutical compositions containing them
02/23/1993CA1313870C Derivatives of morpholine and their preparation process
02/23/1993CA1313868C Orally active nonaddicting analgesics
02/23/1993CA1313823C Method of treating anxiety with tetrahydrobenz(c,d) indole-6-carboxamides
02/21/1993CA2076443A1 1-(alcoxybenzyl)piperazins amidic compounds, process for their preparation and pharmaceutical compositions containing same
02/20/1993CA2076321A1 Method for reduction of central nervous system (cns) edema resulting from head and spinal cord trauma
02/18/1993WO1993003148A2 Tau/neurofilament protein kinases pk40 and pk36
02/18/1993WO1993003059A1 Cyclic hexapeptides as tachyquinin antagonists, their preparation and pharmaceutical compositions thereof
02/18/1993WO1993003049A1 New ganglioside derivatives
02/18/1993WO1993003041A1 Geneserine derivatives as cholinesterase inhibitors
02/18/1993WO1993003034A1 Quinazoline derivatives as acetylcholinesterase inhibitors
02/18/1993WO1993003016A1 Benzimidazolone derivatives as 5-ht1a and 5-ht2 antagonists
02/18/1993WO1993003015A1 Heteroalkoxy benzazepines
02/18/1993WO1993002685A1 Plasmalopsychosines and plasmalocerebrosides and methods of treating neuronal diseases employing the same
02/18/1993WO1993002677A1 5-ht4 receptor antagonists
02/18/1993WO1992022527A3 3-substituted pyrrolidine derivatives as calcium channel antagonists
02/18/1993WO1992019613A3 1,2-dithiole-3-thione derivative-based therapeutical compositions
02/18/1993CA2115250A1 Geneserine derivatives as cholinesterase inhibitors
02/18/1993CA2113115A1 Quinazoline derivatives as acetylcholinesterase inhibitors
02/18/1993CA2111113A1 Plasmalopsychosines and plasmalocerebrosides and methods of treating neuronal diseases employing the same
02/17/1993EP0527687A2 Novel arylethylamin derivatives, processes for their preparation and pharmaceutical compositions containing them
02/17/1993EP0527540A1 Medicament for the treatment of withdrawal symptoms
02/17/1993EP0527534A1 Quinoline and azaquinoline angiotensin II antagonists
02/17/1993CN1069023A 4-(2-hydroxy-2-phenylethylamino) ethoxy) phenylacetic acid derivatives used in therapy obesity and related state
02/17/1993CN1069022A 4-(2-(2-hydroxy-2-phenylethylamino) ethoxy) phenylacetic acid derivatives used in therapy obesity and related state
02/16/1993US5187277 DL-3-[4-[4-(2-pyridyl)-1-piperazinyl]-butyl]-1,8,8-trimethyl-3-azabicyclo[(3]octane-2,4-dione having psychotropic and antiemetic effect
02/16/1993US5187171 Use of a glycine b partial agonist as an antipsychotic
02/16/1993US5187169 Method for treatment of neurodegenerative diseases
02/16/1993US5187153 Methods of treatment using Alzheimer's amyloid polypeptide derivatives
02/16/1993CA2076168A1 Therapeutic agents
02/16/1993CA2076146A1 Piperidine derivatives
02/14/1993CA2075652A1 Quinoline and azaquinoline angiotensin ii antagonists incorporating a substituted benzyl element
02/10/1993EP0527117A1 Substituted cyclopropylamino-1,3,5-triazines
02/10/1993EP0527081A1 Substituted 3-piperazinylalkyl-2,3-dihydro-4H-1,3-benzoxazine-4-ones, their preparation and their therapeutical use
02/10/1993EP0527069A1 Derivatives of pyrrolidine and thiazolidine, their preparation, and pharmaceutical compositions containing them
02/10/1993EP0526865A1 Spongy material consisting essentially of hyaluronic acid or its derivatives, and its use in microsurgery
02/10/1993EP0526708A1 Sulfonamide, preparation and use thereof as medicine and intermediate
02/10/1993EP0526545A1 Isoquinoline amides and esters as 5 ht3 receptor antagonists
02/10/1993EP0526529A1 An improved process for the preparation of substituted indolone derivatives.
02/10/1993EP0526452A1 Hybrid immunoglobulins
02/10/1993EP0309544B1 Psychotropic bicyclic imides
02/10/1993CN1068734A Therapeutic agent
02/09/1993US5185446 Treating anxiety, sleep, seizure disorders
02/09/1993US5185377 Applying locally or by inhalation as antiinflammatory agent, antiallergen, bronchodilator, antiasthmatic, antipsoriatic
02/09/1993US5185369 Treating psychological disorders, nervous system disorders; invertebrate pesticides
02/09/1993US5185368 Complex with trivalent metal ions; medical diagnosis and therapy
02/09/1993US5185350 For Alzheimer*s, memory dysfunctions, antidepressants, antiinflammatory agents
02/09/1993US5185343 Nortropyl-1-alkanol derivatives as antiischemic agents
02/09/1993US5185341 Substituted 5-(phenoxyalkanoylamino)-uracil compounds, methods for making same and pharmaceutical compositions based on same
02/09/1993US5185331 Triazolobenzodiazepines
02/09/1993CA1313499C Use of 2-pyrimidinyl-1-piperazine derivatives
02/06/1993CA2075340A1 Spongy material consisting essentially of hyaluronic acid or its derivatives, and its use in microsurgery
02/04/1993WO1993002206A1 Purification of recombinant ciliary neurotrophic factor and c-terminal truncated ciliary neurotrophic factor and methods for treating peripheral nerve damage
02/04/1993WO1993002095A1 Novel 6-substituted steroids, methods for producing same and pharmaceutical compositions containing said steroids
02/04/1993WO1993002078A1 Benzodiazepine derivatives, compositions containing them and their use in therapy
02/04/1993WO1993002052A1 2-(4-hydroxypiperidino)-1-alkanol derivatives as antiischemic agents
02/04/1993WO1992018475A3 Substituted phenylazacycloalkanes as cns agents
02/04/1993CA2113815A1 Purification of recombinant ciliary neurotrophic factor and c-terminal truncated ciliary neurotrophic factor and methods for treating peripheral nerve damage
02/04/1993CA2113568A1 2-(4-hydroxypiperidino)-1-alkanol derivatives as antiischemic agents
02/04/1993CA2113475A1 Novel 6-substituted steroids, methods for producing same and pharmaceutical compositions containing said steroids
02/04/1993CA2112561A1 Benzodiazepine derivatives, compositions containing them and their use in therapy
02/03/1993WO1993003013A1 Indoline derivatives having an amide function, their preparation, and pharmaceutical compositions containing them
02/03/1993EP0526434A1 Benzimidazolone derivatives as 5-HT1A and 5-HT2 antagonists
02/03/1993EP0526348A1 Indoline derivatives carrying an amide function, their preparation and pharmaceutical compositions containing them
02/03/1993EP0525879A1 Pyrazole derivatives
02/03/1993EP0525584A1 6-Oxo-azepinoindole derivatives, process and intermediates for their preparation and medicaments containing them
02/03/1993EP0525568A1 N-Alkylated 1,4-dihydropyridine carboxylicacid ester derivatives
02/03/1993EP0525537A1 Use of 1,4-dihydropyridine derivatives for the preparation of a medicament for the treatment of neuropathies caused by diabetes mellitus
02/03/1993EP0525420A1 Pseudopeptides and dipeptides characterised by a substituted methyl ketone moiety at the C-terminus as thiol protease inhibitors
02/03/1993EP0524946A1 Treatment of central nervous system disorders with imidazole angiotensin-ii receptor antagonists
02/03/1993EP0386076B1 Phosphoryled derivatives of cardiodilatine/anf peptides
02/03/1993EP0349545B1 New cardiodilatin fragment, process for preparing same and use thereof
02/03/1993EP0308476B1 Bisphenylalkylpiperazine derivatives, a method of their preparation and a pharmaceutical preparation
02/03/1993CN1068566A Alpha-(4-hydroxypiperidino)-1-alkanol derivatives as antiischemic agents
02/02/1993US5183903 Heating together 3-phenoxyazetidine derivative and urea in the absence of a solvent
02/02/1993US5183896 Used for treatment of memory disorders in old people such as senile dementia and Alzheimer's disease
02/01/1993CA2075102A1 6-oxoazepinoindole compounds, processes and intermediates for their preparation and pharmaceutical compositions containing them
02/01/1993CA2074777A1 N-alkylated 1,4-dihydropyridinedicarboxylic acid esters
01/1993
01/31/1993CA2074709A1 Use of 1,4-dihydropyridines in diabetes
01/27/1993EP0524846A1 2-(Piperidin-1-yl)ethanol derivatives, their preparation and their use in therapeutics